Implanet S.A. (IMPZY) Stock

About Implanet S.A.

Implanet S.A., along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications. The firm's product range encompasses solutions for spinal conditions and knee replacements. Specifically, its spinal offerings feature a variety of posterior fixation systems, including the Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw. For knee patients, Implanet also supplies prosthetic devices under the Madison brand. The company maintains a significant strategic alliance with Shanghai Sanyou Medical Co, Ltd. Established in 2006, Implanet S.A. is based in Martillac, France.

Implanet S.A. is headquartered in FR.

Implanet S.A. (IMPZY) stock trades at $0.08 with a market capitalization of $230.11M. The stock is valued at a price-to-earnings (P/E) ratio of -5.46, price-to-book of 68.45, price-to-sales of 1.93. Over the past 52 weeks the stock has ranged between $0.08 and $0.08, and currently trades at its 52-week high.

On profitability, Implanet S.A. generates a return on equity (ROE) of 912.92% — well above the market average, a sign of a high-quality business, return on capital employed of -440.74%, an operating margin of -43.71%, a net profit margin of -35.13%.

Official website: www.implanet.com